Complete response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is time for a paradigm shift in surgical treatment?

被引：0
|
作者：
Flammia, R. S. [1 ]
Tuderti, G. [1 ]
Mastroianni, R. [1 ]
Brassetti, A. [1 ]
Bove, A. M. [1 ]
Proietti, F. [1 ]
Misuraca, L. [1 ]
D'Annunzio, S. [1 ]
Chiacchio, G. [1 ]
Minore, A. [1 ]
Basile, S. [1 ]
Anceschi, U. [1 ]
Ferriero, M. C. [1 ]
Guaglianone, S. [1 ]
Leonardo, C. [1 ]
Simone, G. [1 ]
机构：
[1] IRCCS Regina Elena Natl Canc Inst, Dept Urol, Rome, Italy
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P217
引用
收藏
页码：S300 / S301
页数：2
相关论文
共 50 条
  • [41] Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer
    Alva, Ajjai S.
    Tallman, Christopher T.
    He, Chang
    Hussain, Maha H.
    Hafez, Khaled
    Montie, James E.
    Smith, David C.
    Weizer, Alon Z.
    Wood, David
    Lee, Cheryl T.
    CANCER, 2012, 118 (01) : 44 - 53
  • [42] SURVIVAL ANALYSIS AND PREDICTORS OF NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE IN CLINICAL COMPLETE-RESPONDERS AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
    Vila-Reyes, Helena
    Lee, Kevin
    Decastro, G. Joel
    Li, Gen
    Haas, Christopher R.
    Pak, Jamie S.
    Faiena, Izak
    Anderson, Christopher B.
    McKiernan, James M.
    JOURNAL OF UROLOGY, 2020, 203 : E1274 - E1274
  • [43] The Role of Neoadjuvant Chemotherapy in Bladder Preservation Approaches in Muscle-Invasive Bladder Cancer
    Stecca, Carlos
    Mitin, Timur
    Sridhar, Srikala S.
    SEMINARS IN RADIATION ONCOLOGY, 2023, 33 (01) : 51 - 55
  • [44] ASSESSING CANCER PROGRESSION AND STABLE DISEASE AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
    Chappidi, Meera
    Kates, Max
    Brant, Aaron
    Baras, Alexander
    Netto, George
    Hahn, Noah
    Pierorazio, Phillip
    Schoenberg, Mark
    Bivalacqua, Trinity
    JOURNAL OF UROLOGY, 2016, 195 (04): : E666 - E666
  • [45] Use of treatment pathway improves neoadjuvant chemotherapy use in muscle-invasive bladder cancer
    Faraj, Kassem S.
    Navaratnam, Anojan K.
    Eversman, Sarah
    Elias, Laila
    Syal, Amit
    Tyson, Mark D.
    Castle, Erik P.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (06) : 1111 - 1118
  • [46] ETIOLOGY OF TREATMENT DELAYS IN PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
    El-Arabi, Ahmad
    Sherman, Garth
    Holzbeierlein, Jeffrey
    Lee, Eugene
    Wulff-Burchfield, Elizabeth
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1025 - E1026
  • [47] Etiology of Treatment Delays in Patients Receiving Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    El-Arabi, Ahmad M.
    Alam, Syed M.
    Sherman, Garth
    Parker, William P.
    Thompson, Jeffrey
    Holzbeierlein, Jeffrey M.
    Lee, Eugene K.
    Wulff-Burchfield, Elizabeth M.
    BLADDER CANCER, 2020, 6 (04) : 435 - 444
  • [48] Use of treatment pathway improves neoadjuvant chemotherapy use in muscle-invasive bladder cancer
    Kassem S. Faraj
    Anojan K. Navaratnam
    Sarah Eversman
    Laila Elias
    Amit Syal
    Mark D. Tyson
    Erik P. Castle
    International Urology and Nephrology, 2021, 53 : 1111 - 1118
  • [49] Everything Old Is New Again! Neoadjuvant Chemotherapy in the Treatment of Muscle-Invasive Bladder Cancer
    Sternberg, Cora N.
    Apolo, Andrea B.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (18) : 1868 - 1870
  • [50] Re: Predicting the Pathologic Complete Response after Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer Editorial Comment
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2022, 207 (05): : 1154 - 1155
12345